Is Charles River Laboratories Stock Underperforming the Dow?

Valued at a market cap of $10.6 billion, Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. The Wilmington, Massachusetts-based company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions accelerate their research and drug development efforts. 

Companies valued at $10 billion or more are generally described as “large-cap” stocks, and Charles River Laboratories fits this criterion perfectly. The company has 150 facilities, operates in 21 countries, and employs more than 21,000 people worldwide. It provides support in various fields, including fundamental research, drug discovery, safety and efficacy, clinical support, and manufacturing.